- Investor conference call and webcast to discuss data and clinical trial plans on June 2, 2025, at 7:00 a.m. CT / 8:00 a.m. ET / 8:00 p.m. HKT SHANGHAI & CAMBRIDGE, Mass., April 23, 2025--(BUSINESS ...
SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that it will present findings from preclinical studies highlighting the therapeutic potential ...
ADC Bio has extended its North Wales, UK facility with a new £125,000 Technical Service Laboratory. Commissioned last month (April), the new lab at St. Asaph will meet growing demand for the company's ...
[Carlos] needed an ADC with a 50 nanosecond sample period for his laser lab, that’s 20Msps! (20 million samples a second). While in recent years, commodity ADCs reaching into the low GSPS have become ...
- Zai Lab (ZLAB) will highlight potential of ZL-1310 as a promising, best-in-class Delta-like ligand (DLL3-targeted) ADC for patients with extensive-stage small cell lung cancer (ES-SCLC) - Investor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback